Journal
SCIENCE
Volume 316, Issue 5829, Pages 1345-1348Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1142984
Keywords
-
Categories
Funding
- MRC [G9202171, G0700142] Funding Source: UKRI
- Medical Research Council [G9202171, G0700142] Funding Source: researchfish
- Medical Research Council [G0700142, G9202171] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
Human cytomegalovirus infection perturbs multiple cellular processes that could promote the release of proapoptotic stimuli. Consequently, it encodes mechanisms to prevent cell death during infection. Using rotenone, a potent inhibitor of the mitochondrial enzyme complex I (reduced nicotinamide adenine dinucleotide-ubiquinone oxido-reductase), we found that human cytomegalovirus infection protected cells from rotenone-induced apoptosis, a protection mediated by a 2.7-kilobase virally encoded RNA (beta 2.7). During infection, beta 2.7 RNA interacted with complex I and prevented the relocalization of the essential subunit genes associated with retinoid/interferon-induced mortality-19, in response to apoptotic stimuli. This interaction, which is important for stabilizing the mitochondrial membrane potential, resulted in continued adenosine triphosphate production, which is critical for the successful completion of the virus' life cycle. Complex I targeting by a viral RNA represents a refined strategy to modulate the metabolic viability of the infected host cell.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available